Web Analytics Made Easy - Statcounter

top of page

Multiple Myeloma Clinical Trials @ MSKCC -
Memorial Sloan Kettering Cancer Center NY

Clinical Trials recruiting at MSKCC - Memorial Sloan Kettering Cancer Center

NCT05139225

NCT05139225

NCT05431608

NCT05431608

NCT02671448

NCT02671448

NCT05139225

NCT05139225

1/28

Multiple Myeloma Clinical Trials - Currently Recruiting

NCT05431608: Phase 1: A Study of MCARH109 and MCARH125 in People With Multiple Myeloma

2022 - (R) NCT05431608

Phase 1: A Study of MCARH109 and MCARH125 in People With Multiple Myeloma

NCT05393804: Phase 2: Trial of CART Ide-cel (bb2121) Status Post Hematopoietic cell Transplantation

2022 - (R) NCT05393804

Phase 2: Trial of CART Ide-cel (bb2121) Status Post Hematopoietic cell Transplantation

NCT05354557: Phase 2 - Study of Iberdomide in Multiple Myeloma Post ASCT Transplant

2022 - (R) NCT05354557

Phase 2 - Study of Iberdomide in Multiple Myeloma Post ASCT Transplant

NCT05130827: Phase 2: Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing ASCT

2022 - (R) NCT05130827

Phase 2: Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing ASCT

NCT05032820: Phase 2: MM CAR-T to Upgrade Response BMT CTN 1902

2022 - (R) NCT05032820

Phase 2: MM CAR-T to Upgrade Response BMT CTN 1902

NCT05027594: Phase 1: Study of NMS-03597812 in Adult Pts With Relapsed or Refractory Myeloma

2022 - (R) NCT05027594

Phase 1: Study of NMS-03597812 in Adult Pts With Relapsed or Refractory Myeloma

NCT05024045: Phase 1 - Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

2022 - (R) NCT05024045

Phase 1 - Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

NCT05139225: Phase 1: A Study of TTI-621 and TTI-622 in Combination With Daratumumab RRMM

2021 - (R) NCT05139225

Phase 1: A Study of TTI-621 and TTI-622 in Combination With Daratumumab RRMM

NCT05000450: Phase 1/2: Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell RRMM

2021 - (R) NCT05000450

Phase 1/2: Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell RRMM

United States - Myeloma Clinical Trials | MCT Index (themyelomaclinicaltrials.com)

bottom of page